ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05340	Primary immunodeficiency	12/222	30/7206	2.88406126236e-11
ko05164	Influenza A	24/222	167/7206	2.02679983015e-10
ko04650	Natural killer cell mediated cytotoxicity	18/222	97/7206	6.10702190701e-10
ko04060	Cytokine-cytokine receptor interaction	24/222	191/7206	3.32844007507e-09
ko04612	Antigen processing and presentation	14/222	77/7206	6.92818150068e-08
ko05162	Measles	17/222	120/7206	1.25180612891e-07
ko05168	Herpes simplex infection	21/222	182/7206	1.51214126513e-07
ko04621	NOD-like receptor signaling pathway	19/222	157/7206	2.87478446568e-07
ko05133	Pertussis	14/222	87/7206	3.39376244789e-07
ko04380	Osteoclast differentiation	17/222	134/7206	6.33984234182e-07
ko04217	Necroptosis	19/222	178/7206	2.01838643668e-06
ko05330	Allograft rejection	7/222	24/7206	5.303878791e-06
ko04660	T cell receptor signaling pathway	15/222	124/7206	5.40059789429e-06
ko05150	Staphylococcus aureus infection	8/222	36/7206	1.02746906946e-05
ko05320	Autoimmune thyroid disease	7/222	29/7206	2.09694507015e-05
ko05145	Toxoplasmosis	14/222	126/7206	2.97938716676e-05
ko04658	Th1 and Th2 cell differentiation	12/222	96/7206	3.45128410118e-05
ko04064	NF-kappa B signaling pathway	12/222	96/7206	3.45128410118e-05
ko04062	Chemokine signaling pathway	18/222	201/7206	4.30722564298e-05
ko05152	Tuberculosis	17/222	187/7206	5.84255413618e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	17/222	191/7206	7.62637142281e-05
ko04659	Th17 cell differentiation	12/222	106/7206	9.26856426169e-05
ko04622	RIG-I-like receptor signaling pathway	9/222	62/7206	0.000104087382938
ko04672	Intestinal immune network for IgA production	7/222	37/7206	0.000112119134915
ko05332	Graft-versus-host disease	5/222	18/7206	0.000163697444793
ko04630	Jak-STAT signaling pathway	13/222	132/7206	0.000199211664466
ko03050	Proteasome	8/222	54/7206	0.00021911240147
ko04623	Cytosolic DNA-sensing pathway	7/222	41/7206	0.000220477550659
ko04620	Toll-like receptor signaling pathway	11/222	100/7206	0.000235174505793
ko05161	Hepatitis B	15/222	173/7206	0.000270370881694
ko04662	B cell receptor signaling pathway	10/222	88/7206	0.00034638848647
ko04666	Fc gamma R-mediated phagocytosis	12/222	122/7206	0.000354298414131
ko05160	Hepatitis C	13/222	153/7206	0.000836789817137
ko04210	Apoptosis	14/222	180/7206	0.00127093493464
ko05310	Asthma	4/222	17/7206	0.00152112832704
ko05321	Inflammatory bowel disease (IBD)	7/222	56/7206	0.00153772619363
ko05140	Leishmaniasis	8/222	75/7206	0.0020417576923
ko04940	Type I diabetes mellitus	5/222	32/7206	0.00270737397836
ko04610	Complement and coagulation cascades	8/222	79/7206	0.00284241552925
ko00120	Primary bile acid biosynthesis	4/222	20/7206	0.00287990701335
ko05131	Shigellosis	8/222	82/7206	0.0035893182638
ko05416	Viral myocarditis	6/222	55/7206	0.00657042662084
ko04664	Fc epsilon RI signaling pathway	7/222	77/7206	0.00925841145243
ko05034	Alcoholism	1/222	238/7206	0.0110950254656
ko04145	Phagosome	11/222	162/7206	0.0171605472317
ko00966	Glucosinolate biosynthesis	1/222	1/7206	0.0308076602831
ko05132	Salmonella infection	7/222	98/7206	0.0311043702687
ko04390	Hippo signaling pathway	1/222	188/7206	0.0315051387561
ko05020	Prion diseases	4/222	40/7206	0.0336940209659
ko04611	Platelet activation	10/222	163/7206	0.0344986328864
ko00051	Fructose and mannose metabolism	4/222	42/7206	0.0393657822777
ko00511	Other glycan degradation	3/222	26/7206	0.0445340171724
ko04723	Retrograde endocannabinoid signaling	1/222	175/7206	0.0452806769417
ko05224	Breast cancer	1/222	174/7206	0.0452826629683
ko04310	Wnt signaling pathway	1/222	181/7206	0.0460870412318
ko04728	Dopaminergic synapse	1/222	185/7206	0.0473967187808
ko05144	Malaria	4/222	45/7206	0.0488331684375